Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.

MLA

Xiong, Y. Q., et al. “Comparative Efficacies of Liposomal Amikacin (MiKasome) plus Oxacillin versus Conventional Amikacin plus Oxacillin in Experimental Endocarditis Induced by Staphylococcus Aureus: Microbiological and Echocardiographic Analyses.” Antimicrobial Agents and Chemotherapy, vol. 43, no. 7, July 1999, pp. 1737–42. EBSCOhost, https://doi.org/10.1128/AAC.43.7.1737.

APA

Xiong, Y. Q., Kupferwasser, L. I., Zack, P. M., & Bayer, A. S. (1999). Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses. Antimicrobial Agents and Chemotherapy, 43(7), 1737–1742. https://doi.org/10.1128/AAC.43.7.1737

Chicago

Xiong, Y Q, L I Kupferwasser, P M Zack, and A S Bayer. 1999. “Comparative Efficacies of Liposomal Amikacin (MiKasome) plus Oxacillin versus Conventional Amikacin plus Oxacillin in Experimental Endocarditis Induced by Staphylococcus Aureus: Microbiological and Echocardiographic Analyses.” Antimicrobial Agents and Chemotherapy 43 (7): 1737–42. doi:10.1128/AAC.43.7.1737.